1[3]Lok ASF,Heathente EJ,Hoofnagle JH.Management of hepatitis B 2000:summary of a workshop.Gastroenterology,2001,120(7):1828-1853
2[4]Yuen MF,Hui CK,Cheng CC,et al.Long-term follow-up patients with chronic hepatitis B infection:the effect on hepatitis B e-antigen seroconversion and the development of cirrhosis-related complications.Hepatology,2001,34(1):139-145
3[5]Perrllo RP.Acute flares in chronic hepatitis B:the natural and unnatural history of an immunologyically mediated infection.Gastroenterology,2001,120(4):1009-1022
4Core Working Party For Asia-Pacific Consensus On Hepatitis B And C.Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region[].Journal of Gastroenterology.2000
5Niederau C,Heintges T,Lange S,et al.Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B[].The New England Journal of Medicine.1996
6Heathcote EJ,Jeffers L,Wright T,et al.Loss of serum HBV DNA and HBeAg and seroconversion following short-term ( 12 weeks) adefovir dipivoxil therapy in chronic hepatitis B: two placebo-controlled phase Ⅱ studies ( abstr )[].Hepatology.1998
7Pastore G,Santantonio T,Milella A,et al.Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum: respones to a 6month course of lymphoblastoid interferon[].Journal of Hepatology.1992
8Perrillo RP,Wright T,Rakela J,et al.A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B[].Hepatology.2001
9Chien RN,Liao YF,Chen TC,et al.Efficacy of thymosinα1 in patients with chronic type B hepatitis: a randomized controlled trial[].Hepatology.1998
10Chang TT,Lai CL,Liaw YF,et al.Incremental increases in HBeAg seroconversion and continued ALT normalization in Asian chronic HBV patients treated with lamivudine for four years(abstr)[].Antiviral Therapy.2000
